Stem Cell Therapeutics Announces Shareholder Approval of Share Consolidation Proposal

... in the stem cell biotechnology sector based on the intellectual property of Dr. Samuel Weiss in stem cell research. SCT proposes to build upon the foundational technologies by acquiring additional early-stage clinical or late-stage preclinical ...

http://www.marketwire.com/press-release/stem-cell-therapeutics-announces-shareholder-approval-share-consolidation-proposal-tsx-venture-sss-1740405.htm